Month: May 2020

Highlights for the quarter ended March 31, 2020:Parsippany, New Jersey, May 13, 2020 (GLOBE NEWSWIRE) — Wireless Telecom Group, Inc. (NYSE American: WTT) (the “Company”) announced today results for the first quarter ended March 31, 2020.Tim Whelan, CEO of Wireless Telecom Group, Inc., commented, “Our Q1 financial results were in line with our expectations and reflected declines from weak bookings exiting 2019. Despite lower revenue, our cost reductions and supply chain management efforts helped us improve our gross margins.” Whelan added, “Like so many companies, we saw a softening in new bookings and revenues in the last weeks of March which we believe are attributable to the impact of COVID-19. The adverse impact of the pandemic on the U.S. and global economies is being felt and we may continue to encounter interruptions in supply...

– John English resigns as president and CEO, succeeded by Julia Otey-Raudes     – New corporate direction will utilize novel and disruptive technology to produce highly efficient green energy  VAN NUYS, Calif. , May 13, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Eco Innovation Group, Inc. (OTC: ECOX) (“ECOX” or the “Company”), an innovative developer of renewable energy technology, today announces the resignation of John English from his roles as chairman of the board, chief executive officer and treasurer of the Company.“It has been an honor to lead ECOX these past years and to serve the stakeholders and dedicated staff who have been part of the development of this company,” English said. “I am proud of what we have accomplished as we pursue the interests of the Company and bring value...

Tampa, FL, May 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — REMSleep Holdings, Inc. (OTC PINK: RMSL) eliminated the third of three toxic convertible notes from its balance sheet.REMSleep Holdings, Inc. (OTC Pink: RMSL) has now eliminated three of three convertible notes totaling almost $250,000.00 from its balance sheet. The third note had come due on April 15, 2020. REMSleep was able to negotiate and pay off the third note before any RMSL stock was converted and sold into the market. In October of 2019, REMSleep Holdings sold convertible debt in the form of three different notes to three different investors to raise the capital required to take its flagship product, the DeltaWave CPAP mask, to market. The notes were scheduled to come due on April 15, 2020, at which time, the debt holders would have had an option to convert...

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK) (“MacDonald Mines”, “MacDonald” or the “Company”) announces that, with strict health protocols in place, it has resumed its 2020 drilling program after temporarily suspending operations due to COVID-19 at its SPJ Project, located 40 km east of Sudbury, Ontario. The Company remains well funded as the Spring 2020 exploration program continues. Results from 2 holes from the winter 2020 drilling program are still pending and will be released when they are received.The ongoing resource definition drilling program is focused on quantifying the size and grade of the high-grade gold mineralization in the North Pit area of the Scadding Deposit. Results from the 12 holes drilled this winter, prior to the COVID shutdown, indicate that gold mineralization...

FLORHAM PARK, N.J., May 13, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced its financial results for the first quarter ended March 31, 2020 and provided a business update.First Quarter 2020 and Recent Business HighlightsInitiated novel vaccine development programs for COVID-19 and universal influenza;Announced pre-clinical collaboration with Farmacore Biotechnology for tuberculosis;Delayed initiation of Phase 2 VERSATILE-002 trial for PDS0101 in recurrent/metastatic head and neck cancer due to the global COVID-19 pandemic;Secured the U.S. composition of matter patent for the Versamune® platform;Expanded the previously...

Mountain View, CA, May 13, 2020 (GLOBE NEWSWIRE) — Alphabet’s Loon and Vodacom have signed a deal to use Loon’s balloon-powered internet solution to expand the Vodacom network in Mozambique. In terms of the agreement, Loon will help Vodacom provide service to un-served and under-served parts of the country with a network of floating cell phone towers that operate 20 kilometres above Earth. Using the Loon solution, Vodacom will expand mobile network access to Cabo Delgado and Niassa provinces, two regions that have proven hard to cover in the past due to the vast and logistically challenging geographical areas, together with low population density. The Loon solution will provide a 4G service that supports Data, Voice, SMS and USSD, which will also enable mobile financial services. The service will be available to any Vodacom subscriber...

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Pasha Brands Ltd. (the “Company” or “Pasha”) (CSE: CRFT) (OTC:CRFTF) (FSE:ZZD1) is pleased to announce it has signed a master processing agreement (the “MPA”) with Indiva Limited (“Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) to manufacture and distribute pre-rolls and jarred flower curated from Pasha’s wholly-owned subsidiary, BC Craft Supply Co Ltd.’s, vast national network of artisanal cannabis growers. This partnership intends to elevate the premium cannabis playing field by highlighting the skills of Canada’s micro-growers and making their unique and beautiful flower available to consumers from coast-to-coast.“This partnership represents a significant step for Pasha in realizing its vision to bring high-quality micro producers into the legal market and to provide an avenue...

NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq: MESO; ASX:MSB), a leader in cellular medicines for inflammatory diseases, announced today that it has successfully completed a capital raising of US$90 million¹ (A$138 million) via a private placement of 43 million shares to existing and new institutional investors at a price of A$3.20 per share. This represents a 7% discount to both the price at the close of trading May 8, 2020 and the five-day volume weighted average price (VWAP).A significant portion of the net proceeds will be used to scale-up manufacturing of the Company’s lead product candidate remestemcel-L for the treatment of critically ill patients suffering with diseases caused by cytokine release syndromes associated with high mortality, particularly COVID-19 acute respiratory distress syndrome (ARDS)....

BOSTON, May 13, 2020 (GLOBE NEWSWIRE) — First Eagle Senior Loan Fund (the “Fund”) (NYSE: TSLF) today announced the declaration of its monthly distribution of $0.086 per common share, payable on June 1, 2020.  Based on the Fund’s share price of $11.82 as of its close on May 12, 2020, the distribution represents an annualized yield of 8.73%.  Information regarding the distribution rate is included for informational purposes only and is not necessarily indicative of future results, the achievement of which cannot be assured.  The distribution rate should not be considered the yield or total return on an investment in the Fund.The following dates apply to this distribution:A portion of the distribution may be treated as paid from sources other than undistributed net investment income, including but not limited to short-term capital gain,...

CytoDyn Submits Requested Datasets to FDA for Biologics License ApplicationVANCOUVER, Washington, May 13, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today confirmed on May 11, 2020, it submitted all remaining parts of the Company’s Biologics License Application (“BLA”) for leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients to the U.S. Food and Drug Administration (“FDA”). Pursuant to FDA guidelines, CytoDyn informed the FDA it had submitted a complete BLA for rolling review.As a next step, the FDA will start reviewing the BLA for completeness and will make a filing decision. After the BLA submission is deemed...